CTMX

CytomX Therapeutics, Inc.
Data: 2026-09-04
Quick Stats
Sep 04, 2026

33.4

AI Score

SELL

0.82

Volume Ratio

TBA

Next Earnings

19

+ve Days (30d)

11

-ve Days (30d)

CTMX Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

CTMX Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

CTMX Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CTMX Daily Out of Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CTMX Daily In the Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CTMX Most Active Options by Volume(near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
CTMX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CTMX Stock Summary

Last updated Sep 04, 2026

CTMX is currently trading at $3.71, positioned below its 200-day moving average of $4.16, suggesting bearish momentum. The stock has a 52-week range of $1.9 to $8.21.

Technical Analysis: The 50-day moving average stands at $3.48, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 60.136, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.048, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CTMX at 33.4/100 with a SELL recommendation.

CTMX (CytomX Therapeutics, Inc.) Indicators

Last updated Sep 04, 2026

Indicator Value
RSI(14) 60.136
CMF (20) 0.048
ROC (10) 13.11
ADX (14) 13.557
Indicator Value
MACD (12,26,9) 0.067
AROONOSC (14) 14.286
WILLAMS %R (14) -24.476
MFI (14) 59.534

CytomX Therapeutics, Inc. is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).

CTMX Moving Averages Analysis

CytomX Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 04, 2026

CTMX (CytomX Therapeutics, Inc.) Simple Moving Averages

Moving Averages are last updated Sep 04, 2026

Days MA
10 3.48
20 3.44
30 3.38
50 3.48
100 3.6
200 4.16

CTMX Fundamental Analysis

P/E (Forward) 14.2045
P/E (Trailing) --
Market Cap ($) 801.9 million
Earnings/Share ($) -0.57
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.3902
EPS Estimate Next Year ($) -0.4731
WallStreet Target Price ($) 12.25
Most Recent Quarter

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.